Morgan Stanley upgraded Assurant (NYSE:AIZ) to Overweight from Equalweight on Wednesday, raising the price target to $285 from $240. The stock currently trades at $242.61.
The firm increased net earned premiums growth expectations by 2.9 percentage points for 2026 and 5.7 points for 2027. Operating EPS forecasts were raised to $21.20 for 2026 and $23.60 for 2027.
Assurant trades at a P/E of 12.39 with a PEG ratio of 0.23. Bond.az analysis indicates the stock is undervalued with a 'GREAT' financial health score.
Assurant's differentiated growth profile positions it to outperform expectations into 2026-2027. The new target implies a 1.2x PEG valuation.
In Q1 2026, Assurant reported EPS of $5.95, beating estimates by 11.84%. Revenue reached $3.42 billion, exceeding forecasts.
